Dyclocainum en es it fr

Dyclocainum Brand names, Dyclocainum Analogs

Dyclocainum Brand Names Mixture

  • No information avaliable

Dyclocainum Chemical_Formula


Dyclocainum RX_link


Dyclocainum fda sheet

Dyclocainum FDA

Dyclocainum msds (material safety sheet)

Dyclocainum Synthesis Reference

No information avaliable

Dyclocainum Molecular Weight

382.52 g/mol

Dyclocainum Melting Point

No information avaliable

Dyclocainum H2O Solubility

Readily soluble as hydrobromide formulation

Dyclocainum State


Dyclocainum LogP


Dyclocainum Dosage Forms

Tablet for oral administration (24.2 or 48.5 mg)

Dyclocainum Indication

For the acute treatment of migraine with or without aura in adults.

Dyclocainum Pharmacology

Eletriptan is a selective 5-hydroxytryptamine 1B/1D receptor agonist. In the anesthetized dog, eletriptan has been shown to reduce carotid arterial blood flow, with only a small increase in arterial blood pressure at high doses. While the effect on blood flow was selective for the carotid arterial bed, decreases in coronary artery diameter were observed. Eletriptan has also been shown to inhibit trigeminal nerve activity in the rat.

Dyclocainum Absorption

Well absorbed after oral administration with a mean absolute bioavailability of approximately 50%.

Dyclocainum side effects and Toxicity

Based on the pharmacology of the 5-HT1B/1D agonists, hypertension or other more serious cardiovascular symptoms could occur on overdose.

Dyclocainum Patient Information

No information avaliable

Dyclocainum Organisms Affected

Humans and other mammals